|
Volumn 158, Issue 10, 2001, Pages 1722-1725
|
Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BIPERIDEN;
HALOPERIDOL;
NEUROLEPTIC AGENT;
PIMOZIDE;
SULPIRIDE;
TANDOSPIRONE;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
HUMAN;
MALE;
MENTAL PERFORMANCE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
SOCIAL INTERACTION;
VERBAL MEMORY;
ANTIPSYCHOTIC AGENTS;
COGNITION DISORDERS;
DRUG THERAPY, COMBINATION;
PIPERAZINES;
PYRIMIDINES;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SEROTONIN AGONISTS;
TREATMENT OUTCOME;
|
EID: 0034810016
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.158.10.1722 Document Type: Article |
Times cited : (197)
|
References (17)
|